SCHEMBL7989959

SCHEMBL7989959

CC(=O)c1ccc(Nc2ccccc2)c(N)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.77
KDM4E B2RXH2 5/20 0.77
MAPT P10636 5/20 0.77
ALDH1A1 P00352 3/20 0.77
HSD17B10 Q99714 3/20 0.77
THRB P10828 2/20 0.77
HPGD P15428 2/20 0.77
AKR1C3 P42330 11/20 0.68
AKR1C2 P52895 11/20 0.68
PRKCI P41743 1/20 0.63
GFER P55789 4/20 0.61
NPC1 O15118 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
GLA P06280 1/20 0.57
RCE1 Q9Y256 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
MAPK13 O15264 1/20 0.54
MAPK12 P53778 1/20 0.54
MAPK11 Q15759 1/20 0.54
MAPK14 Q16539 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2342942 0.87 GAA (1.00) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL11791985 0.87 GAA (0.81) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL9071956 0.85 AKR1C3 (0.69) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL121984 0.84 PRKCI (0.59) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL4002584 0.84 GAA (0.72) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL11391871 0.84 AKR1C3 (0.68) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL4286847 0.84 GAA (0.77) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL2651013 0.84 PRKCI (0.55) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL2649113 0.84 PRKCI (0.55) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL9683164 0.83 GAA (0.70) GAAKDM4EMAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218388-B1 THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE WARNER-LAMBERT COMPANY 2001-04-17 US disclosed